Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Mid Cap | Pharmaceuticals & Drugs
1441.70
10.05
(0.70%)
< Home
< Back
Cipla Ltd. News
>>
Cipla informs about Press Release
>>
Cipla declines on recalling 1.40 lakh vials of Levalbuterol Inhalation Solution in US
>>
Cipla recalls 1.40 lakh vials of Levalbuterol Inhalation Solution in US
>>
Cipla’s arm enters into definitive agreement to acquire 51% stake in QCL
>>
Cipla’s arm inks definitive agreement for acquisition of 100% stake in Duomed
>>
Cipla informs about Press Release
>>
Cipla launches generic drug Sofosbuvir in India
>>
Cipla informs about Press Release
>>
Stempeutics receives ATMP classification from EMA for its novel stem cell drug Stempeucel
>>
Stempeutics Research receives US process patent for its novel stem cell drug ‘Stempeucel’
<<
<
80
81
82
...102
>
>>
10.05 (0.70%) 10.05 (0.70%)